Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Tactic Pharma LLC files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Chandler Robinson - $2.56M in MNPR purchases and sales in the last 12 months
- Kim R. Tsuchimoto - $911K in MNPR purchases and sales in the last 12 months
- Raymond Anderson - $703K in MNPR purchases and sales in the last 12 months
- Christopher M. Starr - $659K in MNPR purchases and sales in the last 12 months
- Patrice Rioux - $111 in MNPR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Tactic Pharma LLC?
Tactic Pharma LLC is a corporate entity, tracked as 10% Owner of Monopar Therapeutics (MNPR). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Tactic Pharma LLC last file a Form 4?
The most recent primary Form 4 on record is dated 24 September 2025, one of 2 filings going back to 2025.
Has Tactic Pharma LLC been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($36.17M) across all tracked filings.
